Neuland Laboratories Ltd. Financials

NSE BSE

15:59 Jul 14

Neuland Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

14548.00

+2,247.00 (+18.27%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

14548.00

+2,247.00 (+18.27%)
15:59 Jul 14

Quality

59/100
High Financial Strength

Valuation

25/100
Expensive Valuation

Technical

54/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	936.91	951.08	1191.2	1558.58	1476.84
Operating Expenses +	790.09	808.45	919.35	1095.99	1153.57
Raw Material	439.66	437.55	487.74	632.43	574.81
Increase Decrease in Cost	-1.24	-15.41	-9.51	-55.14	12.83
Other Manufacturing Expense	120.29	131.36	135.56	156.51	162.87
Employee Cost	149.74	182.47	201.79	257.06	272
Miscellaneous Expenses	81.64	72.48	103.77	105.13	131.06
Operating Profit	146.82	142.63	271.85	462.59	323.27
Other Income	16.1	2.08	9.75	12.54	20.51
Depreciation	39.68	49.04	52.78	59.7	65.55
Interest	17.9	13.5	13.07	14	8.3
Profit before tax and exceptio..	105.33	82.16	215.75	401.44	269.93
Exceptional Items	0	0	0	0	76.4
PBT	105.33	82.16	215.75	401.44	346.33
Provision for Taxation	24.7	18.34	52.23	101.36	86.22
Net Profit	80.63	63.82	163.52	300.08	260.11
NET Profit after MI	80.63	63.82	163.52	300.08	260.11
EPS	62.85	49.74	127.45	233.89	202.74
Operating Profit Margin (%)	15.67	15	22.82	29.68	21.89
Net Profit Margin (%)	8.61	6.71	13.73	19.25	17.61

All Data in Percentage (%)

	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24
Promoter	32.70	32.70	32.60	32.70	32.70
FII	22.10	23.90	26.50	25.70	24.40
MF	7.40	6.30	4.00	4.10	3.90
Others	4.00	3.10	2.70	2.70	3.10

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: